File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD

TitleTreatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD
Authors
Chim, JCSLie, AKWChan, YETLiu, HSYLau, CWYip, SYSim, JWan, TSKMa, ESKLiang, RHSTse, EWCKwong, YL
KeywordsDeep vein thrombosis
Myeloma
PAD
Prognostic factors
Staged approach
VTD
Issue Date2012
PublisherBioMed Central Ltd. The Journal's web site is located at http://www.jhoonline.org
Citation
Journal of Hematology and Oncology, 2012, v. 5 article no. 28 How to Cite?
DOI: http://dx.doi.org/10.1186/1756-8722-5-28
Persistent Identifierhttp://hdl.handle.net/10722/164297
ISI Accession Number ID
WOS:000307870300001

 

DC FieldValueLanguage
dc.contributor.authorChim, JCSen_US
dc.contributor.authorLie, AKWen_US
dc.contributor.authorChan, YETen_US
dc.contributor.authorLiu, HSYen_US
dc.contributor.authorLau, CWen_US
dc.contributor.authorYip, SYen_US
dc.contributor.authorSim, Jen_US
dc.contributor.authorWan, TSKen_US
dc.contributor.authorMa, ESKen_US
dc.contributor.authorLiang, RHSen_US
dc.contributor.authorTse, EWCen_US
dc.contributor.authorKwong, YLen_US
dc.date.accessioned2012-09-20T07:57:45Z-
dc.date.available2012-09-20T07:57:45Z-
dc.date.issued2012en_US
dc.identifier.citationJournal of Hematology and Oncology, 2012, v. 5 article no. 28en_US
dc.identifier.urihttp://hdl.handle.net/10722/164297-
dc.languageengen_US
dc.publisherBioMed Central Ltd. The Journal's web site is located at http://www.jhoonline.org-
dc.relation.ispartofJournal of Hematology and Oncologyen_US
dc.rightsJournal of Hematology & Oncology. Copyright © BioMed Central Ltd.-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectDeep vein thrombosis-
dc.subjectMyeloma-
dc.subjectPAD-
dc.subjectPrognostic factors-
dc.subjectStaged approach-
dc.subjectVTD-
dc.titleTreatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTDen_US
dc.typeArticleen_US
dc.identifier.emailChim, JCS: jcschim@hku.hken_US
dc.identifier.emailLie, AKW: akwlie@hkucc.hku.hken_US
dc.identifier.emailLiang, RHS: rliang@hku.hken_US
dc.identifier.emailTse, EWC: ewctse@hku.hken_US
dc.identifier.emailKwong, YL: ylkwong@hku.hken_US
dc.identifier.authorityChim, JCS=rp00408en_US
dc.identifier.authorityLiang, RHS=rp00345en_US
dc.identifier.authorityTse, EWC=rp00471en_US
dc.identifier.authorityKwong, YL=rp00358en_US
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1186/1756-8722-5-28-
dc.identifier.pmid22682027-
dc.identifier.scopuseid_2-s2.0-84861922411-
dc.identifier.hkuros207277en_US
dc.identifier.volume5en_US
dc.identifier.spage28en_US
dc.identifier.epage28en_US
dc.identifier.eissn1756-8722-
dc.identifier.isiWOS:000307870300001-
dc.identifier.issnl1756-8722-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats